Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.45 |
| ▸ | GSK3B | P49841 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21677866 | 0.95 | ALDH1A1 (0.54) | ALDH1A1KMT2AL3MBTL1MAPK1FFAR1 | |
| SCHEMBL5833853 | 0.94 | ALDH1A1 (0.53) | ALDH1A1KMT2AL3MBTL1MAPK1FFAR1 | |
| SCHEMBL18381104 | 0.92 | ALDH1A1 (0.54) | ALDH1A1KMT2AL3MBTL1MAPK1FFAR1 | |
| SCHEMBL18782519 | 0.92 | ALDH1A1 (0.54) | ALDH1A1KMT2AL3MBTL1MAPK1FFAR1 | |
| SCHEMBL18381100 | 0.90 | ALDH1A1 (0.53) | ALDH1A1KMT2AL3MBTL1MAPK1FFAR1 | |
| SCHEMBL3732372 | 0.88 | ALDH1A1 (0.59) | ALDH1A1KMT2AL3MBTL1MAPK1FFAR1 | |
| SCHEMBL7500299 | 0.87 | ALDH1A1 (0.50) | ALDH1A1KMT2AL3MBTL1MAPK1FFAR1 | |
| SCHEMBL15164337 | 0.87 | ALOX5 (0.60) | ALDH1A1KMT2AL3MBTL1FFAR1POLB | |
| SCHEMBL10687182 | 0.86 | FFAR1 (0.50) | ALDH1A1KMT2AL3MBTL1MAPK1FFAR1 | |
| SCHEMBL8084703 | 0.86 | CNR1 (0.50) | ALDH1A1KMT2AL3MBTL1MAPK1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150191477-A1 | Fluoride Processing Method | GE HEALTHCARE LIMITED (GB) | 2015-07-09 | — | — | US | disclosed |
| US-20150191477-A1 | Fluoride Processing Method | GE HEALTHCARE LIMITED (GB) | 2015-07-09 | — | — | US | disclosed |
| US-8980221-B2 | Fluoride processing method | GE HEALTHCARE LIMITED (GB) | 2015-03-17 | — | — | US | disclosed |
| US-8980221-B2 | Fluoride processing method | GE HEALTHCARE LIMITED (GB) | 2015-03-17 | — | — | US | disclosed |
| US-20100285570-A1 | FLUORIDE PROCESSING METHOD | JACKSON ALEXANDER | 2010-11-11 | — | — | US | disclosed |
| US-20100178242-A1 | LABELLING METHODS | GE HEALTHCARE LIMITED (GB) | 2010-07-15 | — | — | US | disclosed |
| US-20100178242-A1 | LABELLING METHODS | GE HEALTHCARE LIMITED (GB) | 2010-07-15 | — | — | US | disclosed |
| WO-2009083530-A2 | FLUORIDE PROCESSING METHOD | GE HEALTHCARE LIMITED (GB) | 2009-07-09 | — | — | WO | disclosed |
| WO-2008155339-A2 | LABELLING METHODS | GE HEALTHCARE LIMITED (GB) | 2008-12-24 | — | — | WO | disclosed |
| US-5530019-A | FOR TREATMENT OF PROSTATE GLAND DISORDERS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-06-25 | — | — | US | disclosed |
| EP-0648208-A1 | INDOLE DERIVATIVES AS TESTOSTERONE 5 ALPHA-REDUCTASE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-04-19 | — | — | EP | disclosed |
| WO-1994022821-A1 | INDOLE DERIVATIVES AS TESTOSTERONE 5 ALPHA-REDUCTASE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100285570-A1 | FLUORIDE PROCESSING METHOD | SLCO1B1, CTSF, MEN1 | ALDH1A1 1788/4885KMT2A 2326/4885L3MBTL1 4377/4885 |
| US-20100178242-A1 | LABELLING METHODS | FURIN, FGF23, FGF2 | ALDH1A1 2015/4885KMT2A 2877/4885L3MBTL1 4189/4885 |
| US-20150191477-A1 | Fluoride Processing Method | SLCO1B1, CTSF, MEN1 | ALDH1A1 1788/4885KMT2A 2326/4885L3MBTL1 4377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.